Benefits
Powerful anti-inflammatory action
Rapid suppression of allergic and hypersensitivity reactions
Useful in emergency and critical care settings
Long duration of therapeutic effect
USP-compliant quality assurance
Usage Instructions
Administered intravenously, intramuscularly, or as directed by a healthcare professional
Dosage depends on clinical condition, severity, and patient response
Should be used under strict medical supervision
Gradual dose tapering may be required for prolonged therapy
Mechanism of Action
Dexamethasone works by binding to intracellular glucocorticoid receptors, altering gene expression to suppress inflammatory mediators such as prostaglandins and cytokines. This results in reduced inflammation, decreased immune response, and stabilization of cellular membranes.
Indications
Dexamethasone Sodium Phosphate Injection USP 8 mg/2 mL is indicated for the management of:
Severe allergic reactions
Inflammatory and autoimmune disorders
Respiratory conditions such as asthma exacerbations
Cerebral edema
Shock (as adjunct therapy)
Endocrine disorders including adrenal insufficiency
Supportive therapy in certain oncological conditions
Prevention of chemotherapy-induced nausea and vomiting (as part of combination therapy)
Side Effects
Possible side effects may include:
Increased blood glucose levels
Fluid retention
Mood changes
Gastrointestinal discomfort
Increased susceptibility to infections
Long-term use may cause adrenal suppression or osteoporosis
Precautions
Use cautiously in patients with diabetes, hypertension, or cardiovascular disease
Monitor blood glucose and blood pressure during therapy
Avoid abrupt discontinuation after prolonged use
Caution in patients with peptic ulcer disease
Regular monitoring required for long-term therapy
Contraindications
Known hypersensitivity to dexamethasone or other corticosteroids
Systemic fungal infections
Live virus vaccination during high-dose therapy
Uncontrolled systemic infections without appropriate antimicrobial treatment